Dailypharm Live Search Close

Moderna¡¯s COVID-19 vaccine is approved in Korea

By Lee, Hye-Kyung | translator Alice Kang

24.09.13 05:28:58

°¡³ª´Ù¶ó 0
Spikevax JN.1 Inj received accelerated approval in 2 months



A new COVID-19 variant vaccine, which is the only mRNA-based COVID-19 vaccine that will be manufactured domestically (by Samsung Biologics) has been approved in Korea.

The Ministry of Food and Drug Safety (MFDS, Minister: Yu-Kyoung Oh) announced on the 11th that it has authorized the manufacturing and sale of ¡®Spikevax JN.1¡¯ that Moderna Korea applied for.

Like Pfizer's COVID-19 vaccine, which was approved on August 30, Spikevax JN.1 is a vaccine that contains an mRNA designed to express the JN.1 variant antigen as the active ingredient.

It is indicated for the prevention of COVID-19 in persons 12 years of age and older and is administered as a single intramuscular

Lee, Hye-Kyung(hgrace7@dailypharm.com)
If you want to see the full article, please JOIN US (click)